Melatonin as an anti-inflammatory agent in radiotherapy
- 393 Downloads
Radiotherapy is one of the most relevant treatment options for cancer therapy with or without other treatment modalities including immunotherapy, surgery and chemotherapy. Exposure to heavy doses of ionizing radiation during radiotherapy results in short and long term side effects. It appears that many of these side effects are linked to inflammatory responses during treatment or after prolonged use. Inflammation is mediated by various genes and cytokines related to immune system responses caused by massive cell death following radiotherapy. This phenomenon is more obvious, particularly after exposure to clinical doses of radiotherapy. Inflammation is involved in the amplification of acute responses, genomic instability and also long term pathological changes in normal tissues. Moreover, inflammation attenuates responses of the tumor to radiotherapy through some mechanisms such as angiogenesis. Thus, the management of inflammation is one of the most interesting aims in cancer radiotherapy. Melatonin, known as a natural product in the body, has been of much interest for its anti-inflammatory properties. Some studies have proposed melatonin as a novel anti-inflammation agent. This literature review will concentrate on the anti-inflammatory properties of melatonin that may help the management of different inflammatory signaling pathways in both tumor and normal tissues.
KeywordsMelatonin Inflammation Radiotherapy Oxidative stress Immune system
Tehran University of Medical Sciences. Grant number 33480.
Compliance with ethical standards
Conflict of interest
- Ben-David MA et al (2015) Melatonin for Prevention of Breast Radiation Dermatitis: A Phase II, Prospective, Double-Blind Randomized Trial. Isr Med Assoc J IMAJ 18(3–4):188–192Google Scholar
- Cerutti P, Amstad P (1993) Inflammation and oxidative stress in carcinogenesis. Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation and Radiation Injury. Springer, New York, pp 387–390Google Scholar
- Haddadi G et al (2013) Radioprotective effect of melatonin on the cervical spinal cord in irradiated rats. Cell J (Yakhteh) 14(4):246Google Scholar
- Najafi M et al (2016) Radiation-induced oxidative stress at out-of-field lung tissues after pelvis irradiation in rats. Cell J (Yakhteh) 18(3):340Google Scholar
- Nooshinfar E et al (2016) Melatonin, an inhibitory agent in breast cancer. Breast Cancer 24:1–10Google Scholar
- Rezaeyan A et al (2016b) Radioprotective effects of hesperidin on oxidative damages and histopathological changes induced by X-irradiation in rats heart tissue. J Med Phys Assoc Med Phys India 41(3):182Google Scholar
- Rezvani M (2003) Treatment of radiation-induced normal tissue lesions. Iran J Radiat Res 1(2):63–78Google Scholar
- Sewerynek E et al (1995) Oxidative damage in the liver induced by ischemia-reperfusion: protection by melatonin. Hepatogastroenterology 43(10):898–905Google Scholar
- Shirazi A et al (2013b) Evaluation of radio-protective effect of melatonin on whole body irradiation induced liver tissue damage. Cell 14(4):294–297Google Scholar